New Bearings
Skip to sources
Time Machine

Pharmacists

Scrub through 216 years of this role's history — from when it first emerged, through every wave of technology that reshaped it, to the cited projections for where it's heading next.

Mortar, pestle, and US Pharmacopeia — the compounding eraMortar, pestle, and US Pharmacopeia — the compounding era
FDCA (1938) + commercial pharmaceutical manufacturing — the dispensing transitionFDCA (1938) + commercial pharmaceutical manufacturing — the dispensing transition
Medicare / Medicaid (1965) + retail pharmacy computer systems — the volume eraMedicare / Medicaid (1965) + retail pharmacy computer systems — the volume era
Medicare Part D (2006) + Medication Therapy Management — the clinical-services era
COVID-19 vaccination programs — pharmacists as mass immunizers
ScriptPro / Parata robotic dispensing + automatic dispensing cabinetsScriptPro / Parata robotic dispensing + automatic dispensing cabinets
Chain implosion + central-fill automation — the restructuring era
18251850187519001925195019752000now

Drag the dot, click anywhere on the track, or use ← → arrow keys (Shift for 10-year jumps, PgUp/PgDn for 25).

2026
Known today as Pharmacist — Pharm.D. (BLS SOC 29-1051)
US Employment
335K
BLS OEWS May 2024 national estimate, cited in BLS National Employment Matrix for 29-1051. O*NET/BLS OOH reports 335,100 as the employment baseline for 2024-34 projections. Data USA ACS household survey (366,223) runs higher — the establishment/household gap is structural; the OEWS figure is used here for consistency with the BLS projection baseline. The 2024 figure comes amid dramatic chain contraction: CVS had executed 900 store closures (announced 2021), Walgreens announced up to 2,150 closures (June 2024), and Rite Aid had completed Chapter 11 liquidation (October 2025).
Median Annual Wage
$137,480
Source: BLS-OEWS
Chain implosion + central-fill automation — the restructuring eraTool of the era · Chain implosion + central-fill automation — the restructuring era

Three simultaneous forces reshaped retail pharmacy after 2021. First, the mass closure wave: CVS announced 900 US store closures in November 2021 (approximately 10% of its footprint), Walgreens announced up to 2,150 closures (25% of stores) in June 2024, and Rite Aid — which had operated 5,059 stores at its 2008 peak — filed for Chapter 11 bankruptcy in October 2023 and liquidated completely by October 2025. Second, central-fill automation: all three chains had been shifting high-volume chronic-medication fills to central automated facilities (essentially warehouses of robotic dispensing equipment), routing routine refills away from retail pharmacies and leaving retail locations to handle acute prescriptions and clinical services. Third, mail-order and PBM-owned pharmacies (CVS Caremark, Express Scripts) continued capturing the chronic-refill market from retail. The combined effect: fewer retail pharmacy locations, each serving higher patient volumes, with more automation and fewer staff per prescription filled.

The chain closures created a paradox: retail pharmacist employment pressure increased even as BLS projected overall growth, because the new jobs (health-system clinical pharmacy, MTM specialists, ambulatory care) required different credentials and were located in different settings than the retail jobs being eliminated. Pharmacists in rural areas and communities that lost their only drugstore faced the hardest transitions.

Projection cone · present → 2034

What credible sources project

Scrub the slider past now to anchor each scenario on the scrubber. The spread you see below is the range of futures credible sources project for this role.

McKinsey Global Institute (2023)
→ 2030
+8%
McKinsey's July 2023 "Generative AI and the Future of Work in America" projects healthcare as the sector with the largest absolute job gains through 2030, driven by aging-population demand growth that exceeds productivity gains from AI tools. Pharmacists fall within the healthcare professionals category that McKinsey projects as net-growing. The +8% estimate approximates the McKinsey optimistic scenario where clinical-pharmacy expansion (MTM, telepharmacy, integrated health-system practice) absorbs workers displaced from retail by automation and chain closures. McKinsey explicitly models gen AI as augmenting pharmacist cognitive tasks (drug-interaction review, MTM documentation) rather than substituting for the licensed practitioner.
BLS National Employment Matrix 2024-34
→ 2034
+5%
BLS Employment Projections 2024-34 cycle. National Employment Matrix reports base employment of 335,100 (2024) and projected employment of 350,500 (2034), a change of +15,400 (+4.6%, rounded to +5% in OOH). Described as "Faster than average." The retail-trade sector (37.3% of employment) is projected to decline slightly (-1.6%), while health care and social assistance settings are projected to grow, reflecting the clinical-pharmacy shift. BLS cites aging-population prescription volume and MTM clinical-services expansion as primary growth drivers.
O*NET / BLS OOH 2024
→ 2034
+5%
BLS Occupational Outlook Handbook 2024 edition, drawing on the same Employment Projections data. OOH projects 14,200 annual average job openings for pharmacists through 2034, combining new-job growth and replacement needs (retirement and occupational transfer). The OOH framing explicitly notes the shift toward clinical and health-system settings while retail pharmacy contracts. The +5% figure masks significant structural redistribution: retail loses, ambulatory/health-system gains.
Eloundou et al. — "GPTs are GPTs" (2023)
→ 2028
-10%
GPT-4 task-by-task LLM-exposure labeling on O*NET tasks for pharmacists. Pharmacists score moderately on LLM exposure because significant portions of the role involve information processing, patient counseling (which an LLM could partially draft), and drug-interaction checking (which software already handles). The physical dispensing, licensed verification, and patient-contact components score lower on exposure. The -10% estimate represents the range of tasks where LLM augmentation could reduce pharmacist time-on-task substantially without eliminating the role — comparable to how EHR-integrated drug-interaction checking reduced the cognitive load of manual cross-referencing without eliminating pharmacist review. The clinical-services expansion (MTM, immunization) is the structural counter to LLM displacement.
Frey & Osborne (2013)
→ 2033
-50%
Gaussian-process classifier on O*NET task features. Frey & Osborne assigned Pharmacists a probability of computerization of approximately 0.58 (58%) — placing pharmacy in the high-risk segment of their 702-occupation analysis. The risk drivers were the high proportion of routine information-processing tasks (verifying prescriptions, checking insurance eligibility, dispensing counted medications) that F&O assessed as susceptible to software automation. The -50% figure represents the implied employment ceiling if the F&O probability were realized. In practice, the profession has grown modestly since 2013, suggesting F&O overestimated robotic-dispensing substitution speed and underweighted the clinical-pharmacy regulatory and scope-of-practice dynamics that have sustained demand. Treat as the pessimistic tail of the projection cone.
Today, in this role

What's shifting in the work right now

The historical view above shows how this role has moved. This is the present-day detail: which AI tools are picking up which tasks, where the edge still is, and the natural directions this work can grow.

What's changing in your day

Three parts of your work where AI is already doing real lifting — and what stays yours.

AI is sitting alongside you here

Manage prior authorization workflows — processing prior auth requests for specialty medications through AI-assisted platforms (Surescripts Prior Authorization Automation, Latent Health integrated with Epic), reviewing automated determinations for clinical accuracy, escalating complex cases requiring additional clinical documentation, and counseling patients on formulary alternatives when automated PA is denied.[7],[10]

Tools picking this up
Where your edge is

Prior auth automation is cutting routine PA approval time to 18 seconds (Surescripts 2025) and specialty PA throughput by 50%+ at Ochsner Health — the administrative burden that historically consumed pharmacist time is shrinking fast. Your focus shifts to the exception queue: complex, non-standard requests where clinical nuance determines coverage, and to counseling patients on therapeutic alternatives when denial is final. Build expertise in specialty drug coverage policies and payer-specific clinical criteria to own the high-stakes escalations.

AI is sitting alongside you here

Verify and approve prescriptions routed for final pharmacist sign-off from robotic dispensing systems (Omnicell XR2, Walgreens micro-fulfillment robots) — reviewing barcode-verified fill accuracy logs, confirming patient identity and allergy flags in Epic or MEDITECH, releasing the verified prescription for dispensing, and flagging any dosage or substitution anomalies that require pharmacist intervention before the medication leaves the pharmacy.[5],[9],[1]

Tools picking this up
Where your edge is

Robotic dispensing systems now handle the physical fill and barcode verification — your value in this task is clinical judgment on the exception queue: catching allergy conflicts, therapeutic duplication, and dosage anomalies the system flagged. Focus on building fluency with your pharmacy's specific dispenser exception-management interface and develop a systematic review protocol for the high-risk flags (narrow therapeutic index drugs, weight-based dosing) where a miss has patient safety consequences.

AI is sitting alongside you here

Manage pharmacy inventory and automated dispensing cabinet replenishment — using Omnicell OmniSphere cloud analytics to monitor automated dispensing cabinet (ADC) stock levels, generating AI-recommended reorder quantities, reconciling controlled substance diversion reports, and coordinating 340B drug pricing compliance for eligible health system purchases.[6],[1]

Tools picking this up
Where your edge is

Inventory and replenishment are increasingly automated — the Omnicell OmniSphere platform cuts restocking workflow time by 70% per Holzer Regional Medical Center data. Your defensible role here is controlled substance diversion monitoring (requires human accountability and DEA compliance) and 340B compliance oversight — these are regulatory functions with legal consequences that the inventory platform surfaces but a pharmacist must validate and sign off on.

Where this role is heading

Natural next steps for someone with your foundation — not exits, evolutions.

A direction you could grow

Medical and Health Services Managers

Pharmacists who develop operational, regulatory, and financial expertise naturally transition into pharmacy director, director of pharmacy operations, or health system pharmacy leadership roles. As automated dispensing systems absorb routine fill volume, the pharmacy director role — vendor governance, formulary management, 340B program oversight, controlled substance compliance, and AI-tool strategy — becomes more strategically valuable. BLS projects Medical and Health Services Managers at +29% growth 2024-2034, one of the fastest-growing management occupations. Pharmacy directors at hospital systems command salaries of $160,000–$220,000+. The PharmD credential plus operational experience maps directly to the credentialing requirement.

What you'd add
· Healthcare operations management: staffing models, departmental P&L, productivity benchmarking against ASHP pharmacy staffing standards
· 340B drug pricing compliance: covered entity eligibility, split-billing software, OPA audit readiness
What it takesSome new skills to pick up
Present-day sources

Sources

Every claim on this page traces back to one of the following. Updated 2026-05-23.

  1. [1]O*NET 30.3 — Pharmacists (29-1051.00): tasks, technology skills, work activities, employment data· accessed 2026-05-23
  2. [2]BLS OOH — Pharmacists: 335,100 employed 2024; +5% growth 2024-2034; 14,200 annual openings; median $137,480· accessed 2026-05-23
  3. [3]Drug Channels — Pharmacist Salaries and Employment in 2024: retail down 8,500; hospital +7.3% to ~100K; community share falling to projected 49% by 2033· accessed 2026-05-23
  4. [4]Walgreens doubles down on robots — CNBC May 2025: 11 micro-fulfillment centers; 5,000+ store target; $500M saved; 1,200+ store closures 2024-2025· accessed 2026-05-23
  5. [5]Omnicell XR2 — Ballad Health deployment: zero medication picking errors in 9M+ doses; 100% barcode scan; 60,000+ unit-dose capacity· accessed 2026-05-23
  6. [6]Omnicell Titan XT — December 2025: OmniSphere cloud medication management; 70% time savings on restocking reported by Holzer Regional Medical Center· accessed 2026-05-23
  7. [7]Surescripts 2025 Annual Impact Report — 30.5B transactions; PA Automation 18-sec median approval; RTPB 1B uses; $55.1M patient savings· accessed 2026-05-23
  8. [8]Surescripts — Prior Authorization Automation expansion May 2026: 68,000 prescribers at 42 health systems; 50% prescriber base expansion since Dec 2025· accessed 2026-05-23
  9. [9]Pharmacy Times — Intelligent Pharmacy: pharmacist productivity +33% with automation; 45% more patient-facing time; Walgreens fills 60% Rx robotically· accessed 2026-05-23
  10. [10]Pharmacy Times / Ochsner Health — Latent Health AI in Epic: specialty PA throughput +96%; reauth cycle times -50%; 4-min clinical review avg· accessed 2026-05-23
  11. [11]ASHP Statement on AI in Pharmacy (AJHP 2025) — AI reduces time on routine tasks; pharmacists must be active implementation partners; AI creates new roles and alters scope of patient care· accessed 2026-05-23
  12. [12]Eloundou et al. 2024 — GPTs are GPTs (Science): occupational LLM exposure framework· accessed 2026-05-23
Share this year
Drops anyone you send it to straight into 2026.
Preview card
Different role?

See the same long-arc view for your own profession.

Browse the directory by industry, or search by title or SOC code. New roles ship every few weeks — every profile cites every claim.

Browse all roles